These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 4791053)
1. Metabolism of delta-aminolaevulinic acid and porphobilinogen in human erythrocytes in acute intermittent porphyria. Doss M Enzyme; 1973; 16(1):343-53. PubMed ID: 4791053 [No Abstract] [Full Text] [Related]
2. Intermittent acute porphyria--demonstration of a genetic defect in porphobilinogen metabolism. Meyer UA; Strand LJ; Doss M; Rees AC; Marver HS N Engl J Med; 1972 Jun; 286(24):1277-82. PubMed ID: 5024458 [No Abstract] [Full Text] [Related]
3. [On the biochemical pathogenesis of acute intermittent porphyria]. Heilmeyer L Munch Med Wochenschr; 1969 Apr; 111(16):905-9. PubMed ID: 5819143 [No Abstract] [Full Text] [Related]
4. [Hepatic porphyrias]. Crispin M; Szeinberg A Harefuah; 1972 Feb; 82(3):137-9. PubMed ID: 4565661 [No Abstract] [Full Text] [Related]
5. Repression of the overproduction of porphyrin precursors in acute intermittent porphyria by intravenous infusions of hematin. Bonkowsky HL; Tschudy DP; Collins A; Doherty J; Bossenmaier I; Cardinal R; Watson CJ Proc Natl Acad Sci U S A; 1971 Nov; 68(11):2725-9. PubMed ID: 5288250 [TBL] [Abstract][Full Text] [Related]
6. Significance of the porphyrin precursors delta-aminolaevulinic acid (ALA) and porphobilinogen (PBG) in the acute attack of porphyria. Kramer S; Becker D; Viljoen D S Afr Med J; 1973 Sep; 47(38):1735-8. PubMed ID: 4270402 [No Abstract] [Full Text] [Related]
7. Plasma porphyrin concentrations in porphyria cutanea tarda. Moore MR; Thompson GG; Allen BR; Hunter JA; Parker S Clin Sci Mol Med; 1973 Nov; 45(5):711-4. PubMed ID: 4759516 [No Abstract] [Full Text] [Related]
8. Acute intermittent porphyria in Poland. Darocha T; Gregor A S Afr Med J; 1971 Sep; ():204-17. PubMed ID: 5150281 [No Abstract] [Full Text] [Related]
9. [Acute intermittent porphyria in 3 generations. Neurological and biochemical studies]. Mühler E; Doss M Med Welt; 1977 Jul; 28(27):1177-9. PubMed ID: 886970 [No Abstract] [Full Text] [Related]
11. [On the problem of treatment of acute intermittent porphyria with ovulation inhibitors. (Studies of delta-aminolevulinic acid, porphobilinogen and total porphyrin excretion)]. Hocevar V; Rausch-Stroomann JG Klin Wochenschr; 1968 Oct; 46(20):1114-6. PubMed ID: 5706556 [No Abstract] [Full Text] [Related]
14. Acute intermittent porphyria. A clinical, biochemical and family study. Kreimer-Birnbaum M; Mosovich LL; Bannerman RM J Med; 1971; 2(3):149-66. PubMed ID: 5289639 [No Abstract] [Full Text] [Related]
15. [Porphyrins and their precursors in the urine of patients with suspected porphyria; a 16-year experience]. Zawirska B; Kwiatkowska W; Nowojska A Pol Tyg Lek; 1985 Jan; 40(4):97-100. PubMed ID: 3983004 [No Abstract] [Full Text] [Related]
16. The effect of DL-propranolol on delta-aminolevulinic acid synthetase activity and urinary excretion of porphyrins in allylisopropylacetamide-induced experimental porphyria. Blum I; Schoenfeld N; Atsmon A Biochim Biophys Acta; 1973 Sep; 320(2):242-8. PubMed ID: 4750745 [No Abstract] [Full Text] [Related]
17. Determination of 5-aminolaevulinic acid and porphobilinogen by high-performance liquid chromatography. Lim CK; Rideout JM; Samson DM J Chromatogr; 1979 Dec; 185():605-11. PubMed ID: 546936 [TBL] [Abstract][Full Text] [Related]
18. Studies on porphyrin biosynthesis in erythrocytes after incubation with delta-aminolaevulinic acid in patients with acute leukemia. Arsov T; Ivanov E Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(4):567-73. PubMed ID: 6170551 [TBL] [Abstract][Full Text] [Related]